CRYSTAL FORM OF QUINOLINONE COMPOUND AND USE THEREOF

The present invention relates to a crystal form of a quinolinone compound and a use thereof. The present invention further relates to a pharmaceutical composition comprising the crystal form, and a use of the crystal form or the pharmaceutical composition in the preparation of a drug for the treatme...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, LIANG, ZONG, QIAO, ZUO, YINGLIN, WANG, XIAOJUN
Format Patent
LanguageEnglish
French
Published 03.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a crystal form of a quinolinone compound and a use thereof. The present invention further relates to a pharmaceutical composition comprising the crystal form, and a use of the crystal form or the pharmaceutical composition in the preparation of a drug for the treatment and prevention of HIF-related and/or EPO-related diseases (such as anemia). La présente invention concerne une forme cristalline d'un composé de quinolinone et son utilisation. La présente invention concerne en outre une composition pharmaceutique comprenant la forme cristalline, et une utilisation de la forme cristalline ou de la composition pharmaceutique dans la préparation d'un médicament pour le traitement et la prévention de maladies associées au HIF et/ou associées à l'EPO (telles que l'anémie).
Bibliography:Application Number: CA20203156439